FDA comments on phase I clinical trials without vector biodistribution data
- 1 August 1999
- journal article
- other
- Published by Springer Nature in Nature Genetics
- Vol. 22 (4) , 326
- https://doi.org/10.1038/11895
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- An estimated frequency of endogenous insertional mutations in humansNature Genetics, 1999
- The Impact of the Report, Splicing LifeHuman Gene Therapy, 1990
- The Revised “Points to Consider” DocumentHuman Gene Therapy, 1990